午夜福利1000集合

British opponents of gene patenting this week exposed deals that give a
tobacco company exclusive rights to develop and sell vaccines against lung
cancer. 鈥淚t鈥檚 cynical for tobacco companies to profit from diseases that their
own products cause,鈥� says Helen Wallace of GeneWatch. The pressure group
highlights two deals struck by Japan Tobacco, which makes three of the world鈥檚
five top-selling cigarette brands. In one deal, Corixa of Seattle, Washington,
granted Japan Tobacco a licence to develop vaccines based on patented genes that
are uniquely active in lung cancer cells.